Psychiatric Consultation Through Videoconference in a Primary Care Setting

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Sha’ar Menashe Mental Health Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Galil Center for Telemedicine and Medical Informatics
Information provided by:
Sha’ar Menashe Mental Health Center
ClinicalTrials.gov Identifier:
NCT00298961
First received: March 2, 2006
Last updated: May 20, 2008
Last verified: May 2008
  Purpose

In our study we will aim to examine the issues of cost analysis, quality of life, clinical efficacy and satisfaction of psychiatric consultations through videoconference in a primary care setting in comparison with in-person psychiatric treatment and primary care only. The main hypotheses of the study are: Satisfaction of the patients will increase, the use of telepsychiatry will reduce the costs for the primary and mental health care centers as well as for the patients, the treatment will be as effective as in-person treatment, the number of patients referred to mental health treatment will be higher than that of the previous year, quality of life will improve and that there will be a stigma reduction of mental illness.


Condition Intervention
Remote Consultation
Community Psychiatry
Device: Videoconference equipment FALCON/IP

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Telepsychiatry: Cost Analysis, Quality of Life, Satisfaction and Effectiveness of Psychiatric Consultation Through Videoconference in a Primary Care Setting

Resource links provided by NLM:


Further study details as provided by Sha’ar Menashe Mental Health Center:

Primary Outcome Measures:
  • Brief Psychiatric Rating Scale (BPRS) at 0 months, 6 months and 12 months.

Secondary Outcome Measures:
  • Clinical Global Impression Scale (CGI) at 0 months, 6 months and 12 months.
  • Hamilton Anxiety Rating Scale (HAM-A) at 0 months, 6 months and 12 months.
  • Hamilton Depression Rating Scale (HAM-D) at 0 months, 6 months and 12 months.
  • Global satisfaction questionnaire at 0 months, 6 months and 12 months.
  • General Health Questionnaire 11 (GHQ11) at 0 months, 6 months and 12 months.
  • Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18) at 0 months, 6 months and 12 months.
  • Costs: Travel expenses, extra consultations, hospitalizations, Medication, loss of work days, medical visitations, ancillary tests such as ECG, lab tests and others at 0 months, 6 months and 12 months.

Estimated Enrollment: 160
Study Start Date: May 2006
Estimated Study Completion Date: November 2007
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients referred by the primary care physician.
  • Age 18 and over.
  • Speak Hebrew.

Exclusion Criteria:

  • Patients that suffer from severe dementia.
  • Patients suffering from addiction to drugs or alcohol.
  • Patients who are deaf, dumb or blind.
  • Patients who have a legal guardian.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00298961

Contacts
Contact: Mahmud Jabarin, MD +972-4-6278110 jabarin@shaar-menashe.org.il
Contact: Ehud Susser, MD +972-4-6278946 udiwudi@yahoo.com

Locations
Israel
Sha'ar Menashe Mental Health Center Ambulatory Clinic Recruiting
Hadera, Israel, 38814
Contact: Mahmud Jabarin, MD    +972-4-6278110    jabarin@shaar-menashe.org.il   
Contact: Ehud Susser, MD    +972-4-6278946    udiwudi@yahoo.com   
Principal Investigator: Mahmud Jabarin, MD         
Sponsors and Collaborators
Sha’ar Menashe Mental Health Center
Galil Center for Telemedicine and Medical Informatics
Investigators
Principal Investigator: Mahmud Jabarin, MD Sha'ar Menashe Mental Health Center, Israel
Study Chair: Ilan Modai, MD, MHA Sha'ar Menashe Mental Health Center, Israel
Study Chair: Ehud Susser, MD Sha'ar Menashe Mental Health Center, Israel
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00298961     History of Changes
Other Study ID Numbers: TelepsychiatryCTIL
Study First Received: March 2, 2006
Last Updated: May 20, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

ClinicalTrials.gov processed this record on July 20, 2014